Worldwide launched some weeks ago, the fully automated MagNA Pure 96 System purifies genomic DNA, viral DNA and RNA, or cellular RNA from a broad range of specimen types, processing 96 standardvolume specimens in less than 1 hour. The new instrument requires just a few disposables and prefilled reagents, all of which can be loaded quickly and easily as needed.
"Sensitivity and specificity are mandatory for our Virology and Bacteriology studies," said Steve Young, PhD, TriCore's scientific director for Infectious Disease. "Furthermore, we need the high capacity and processing speed this instrument offers to provide rapid responses during peak seasonal testing periods."
Used by TriCore in conjunction with Roche's LightCycler® System, the MagNA Pure 96's high processing capacity is crucial for influenza research and for the detection of seasonal Influenza A and B in respiratory specimens. TriCore's current research studies target human cases of pandemic H1N1 2009, which is continuing to increase substantially worldwide.
Other applications of the MagNA Pure 96 System at TriCore include research on Group B Streptococcus, a bacterium that causes lifethreatening infections in newborns, and on Methicillinresistant Staphylococcus aureus (MRSA).
About TriCore Reference Laboratories
With roots that extend back 30 years, Albuquerque, N.M.based TriCore Reference Laboratories is a notforprofit, independent, regional medical reference laboratory providing diagnostic testing for patients and their healthcare providers. As a Southwest regional laboratory leader with more than 1,000 employees and 25 patient care centers, TriCore performs a full range of tests - from the routine to the highly esoteric - under the direction of more than 30 pathologists and scientific directors.
All trademarks used or mentioned in this release are protected by law.
LIGHTCYCLER and MAGNA PURE are trademarks of Roche.